Q3 2020 Holdings
Filed 2020-11-13 | 63 holdings | $14.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $5.5M | 156,982 | 37.0% |
| Cardiff Oncology Inc(CRDF) | COM | 14147L108 | $4.0M | 281,819 | 27.0% |
| Biogen Inc(BIIB) | COM | 09062X103 | $3.3M | 11,556 | 22.1% |
| Axogen Inc(AXGN) | COM | 05463X106 | $1.6M | 135,111 | 10.6% |
| Castle Biosciences Inc(CSTL) | COM | 14843C105 | $323.0K | 6,269 | 2.2% |
| Essa Pharma Inc(EPIEUR) | COM NEW | 29668H708 | $12.6K | 1,826,980 | 0.1% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $9.5K | 1,685,879 | 0.1% |
| Orasure Technologies Inc(OSUR) | COM | 68554V108 | $7.6K | 625,109 | 0.1% |
| Mersana Therapeutics Inc | COM | 59045L106 | $7.3K | 393,041 | 0.0% |
| Inhibrx Inc(INBXUSD) | COM | 45720L107 | $7.3K | 406,500 | 0.0% |
| Natera Inc(NTRA) | COM | 632307104 | $7.3K | 101,089 | 0.0% |
| Quidel Corp | COM | 74838J101 | $6.7K | 30,751 | 0.0% |
| Vericel Corp(VCEL) | COM | 92346J108 | $6.5K | 353,006 | 0.0% |
| Immunomedics Inc(IMMU) | COM | 452907108 | $6.5K | 76,268 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $6.5K | 46,166 | 0.0% |
| Lantheus Hldgs Inc(LNTH) | COM | 516544103 | $6.5K | 509,544 | 0.0% |
| Novocure LTD(NVCR) | ORD SHS | G6674U108 | $5.8K | 52,377 | 0.0% |
| Tcr2 Therapeutics Inc | COM | 87808K106 | $5.7K | 282,041 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $5.5K | 500,264 | 0.0% |
| Iradimed Corp(IRMD) | COM | 46266A109 | $4.2K | 198,739 | 0.0% |
| Zymeworks Inc | COM | 98985W102 | $4.2K | 89,233 | 0.0% |
| Horizon Therapeutics PUB L | SHS | G46188101 | $4.1K | 52,227 | 0.0% |
| Eiger Biopharmaceuticals Inc(CLDNEUR) | COM | 28249U105 | $3.8K | 472,558 | 0.0% |
| Adverum Biotechnologies Inc(ADVMCHF) | COM | 00773U108 | $3.8K | 364,349 | 0.0% |
| Alexion Pharmaceuticals Inc(ALXN) | COM | 015351109 | $3.4K | 30,077 | 0.0% |
| OAK STR Health Inc(OSH3EUR) | COM | 67181A107 | $3.1K | 58,892 | 0.0% |
| Dexcom Inc(DXCM) | COM | 252131107 | $3.1K | 7,583 | 0.0% |
| Surmodics Inc(SU6) | COM | 868873100 | $3.0K | 77,283 | 0.0% |
| Misonix Inc(MSON) | COM | 604871103 | $2.9K | 250,253 | 0.0% |
| Itamar MED LTD | SPONSORED ADS | 465437101 | $2.9K | 140,524 | 0.0% |
| Axonics Modulation Technolog(AXNX*) | COM | 05465P101 | $2.8K | 54,089 | 0.0% |
| Merck & Co. Inc(MRK) | COM | 58933Y105 | $2.2K | 26,579 | 0.0% |
| Zynex Inc(ZYXIQ) | COM | 98986M103 | $2.1K | 118,047 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $1.9K | 20,454 | 0.0% |
| Provention BIO Inc(PRVBUSD) | COM | 74374N102 | $1.8K | 139,418 | 0.0% |
| Protara Therapeutics Inc(TARA) | COM STK | 74365U107 | $1.7K | 100,000 | 0.0% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $1.7K | 11,926 | 0.0% |
| Rafael Hldgs Inc(RFL) | COM CL B | 75062E106 | $1.6K | 104,737 | 0.0% |
| Trillium Therapeutics Inc | COM NEW | 89620X506 | $1.6K | 112,742 | 0.0% |
| Lyra Therapeutics Inc(LYRA) | COM | 55234L105 | $1.2K | 110,670 | 0.0% |
| Larimar Therapeutics Inc(LRMR) | COM | 517125100 | $1.2K | 76,184 | 0.0% |
| Revance Therapeutics Inc(RVNCEUR) | COM | 761330109 | $1.0K | 41,617 | 0.0% |
| Pieris Pharmaceuticals Inc | COM | 720795103 | $1.0K | 500,000 | 0.0% |
| Medicenna Therapeutics Corp(MDNAF) | COM | 58490H107 | $1.0K | 248,860 | 0.0% |
| Gossamer BIO Inc | NOTE 5.000% 6/0 | 38341PAA0 | $1.0K | $1,000,000 | 0.0% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $932 | 19,648 | 0.0% |
| Staar Surgical Co(STAA) | COM PAR $0.01 | 852312305 | $868 | 15,346 | 0.0% |
| Insulet Corp(PODD) | COM | 45784P101 | $859 | 3,632 | 0.0% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $853 | 10,200 | 0.0% |
| Arena Pharmaceuticals Inc(ARNAEUR) | COM NEW | 040047607 | $821 | 10,977 | 0.0% |